Loading...
OTCM
NORD
Market cap77mUSD
Oct 08, Last price  
4.01USD
1D
-0.07%
1Q
63.55%
Jan 2017
7,914.00%
Name

Nordicus Partners Corp

Chart & performance

D1W1MN
OTCM:NORD chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
99.97%
Rev. gr., 5y
-72.78%
Revenues
0
-100.00%
21,151,0003,207,0003,265,0002,117,0001,666,0001,866,0002,195,0002,626,0002,574,0003,181,0002,284,0002,918,0003,346,0002,698,0000002,5005,0000
Net income
-4m
L+37.93%
-5,924,000-12,180,000-5,034,000-3,376,000-6,370,000-3,624,000-1,351,000-835,000-704,000-338,000-877,000-585,000-83,000-408,000-326,000-265,000-8,464,925,000-298,202-2,901,321-4,001,686
CFO
-4m
L+236.66%
-2,259,000-3,652,000-2,723,000-1,613,000-2,592,000-1,752,000-484,000119,000-187,00062,000-203,000108,00081,0005,333,000-323,000-282,000-368,347,000-258,928-1,284,615-4,324,775
Dividend
Mar 10, 20220.25 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Currently, EKIMAS Corporation does not engage in significant business operations. In its earlier years, the company focused on creating specialized polymer materials used in the development of medical devices, designed to address various anatomical regions and health issues. The firm's current objective is to identify, acquire, or combine with an existing operating entity through an equity-for-equity transaction. Established in 1993, this Las Vegas, Nevada-based entity was formerly known as AdvanSource Biomaterials Corporation, changing its name to EKIMAS Corporation in March 2020.

Key people

Michael F. Adams
President, Chief Executive Officer, Director · since 2006
Willaim J. O'Neill
Independent Chairman of the Board · since 2006
Michael L. Barretti
Independent Director · since 1998
Mark R. Tauscher
Independent Director · since 2010
URL
https://nordicuspartners.com/
IPO date
Jun 12, 1996
Employees
11
Domiciled in
US
Incorporated in
US
Legal address
c/o VCORP AGENT SERVICES, INC., 108 W. 13TH STREET SUITE 100
WILMINGTON, DE 19801
US
Headquarters
95 WASHINGTON STREET #154
CANTON, MA 02021
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT